Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

RD Johnston, Stephen; Kilburn, Lucy S; Ellis, Paul; Dodwell, David; Cameron, David; Hayward, Larry; Im, Young-Hyuck; Braybrooke, Jeremy P; Brunt, A Murray; Cheung, Kwok-Leung; Jyothirmayi, Rema; Robinson, Anne; Wardley, Andrew M; Wheatley, Duncan; Howell, Anthony; Coombes, Gill; Sergenson, Nicole; Sin, Hui-Jung; Folkerd, Elizabeth; Dowsett, Mitch; Bliss, Prof Judith M; investigators, SoFEA

doi:10.1016/S1470-2045(13)70322-X

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

RD Johnston, Stephen; Kilburn, Lucy S; Ellis, Paul; Dodwell, David; Cameron, David; Hayward, Larry; Im, Young-Hyuck; Braybrooke, Jeremy P; Brunt, A Murray; Cheung, Kwok-Leung; Jyothirmayi, Rema; Robinson, Anne; Wardley, Andrew M; Wheatley, Duncan; Howell, Anthony; Coombes, Gill; Sergenson, Nicole; Sin, Hui-Jung; Folkerd, Elizabeth; Dowsett, Mitch; Bliss, Prof Judith M; investigators, SoFEA

Authors

Stephen RD Johnston

Lucy S Kilburn

Paul Ellis

David Dodwell

David Cameron

Larry Hayward

Young-Hyuck Im

Jeremy P Braybrooke

Professor Adrian Brunt m.brunt@keele.ac.uk

Kwok-Leung Cheung

Rema Jyothirmayi

Anne Robinson

Andrew M Wardley

Duncan Wheatley

Anthony Howell

Gill Coombes

Nicole Sergenson

Hui-Jung Sin

Elizabeth Folkerd

Mitch Dowsett

Prof Judith M Bliss

SoFEA investigators

Citation

RD Johnston, S., Kilburn, L. S., Ellis, P., Dodwell, D., Cameron, D., Hayward, L., Im, Y.-H., Braybrooke, J. P., Brunt, A. M., Cheung, K.-L., Jyothirmayi, R., Robinson, A., Wardley, A. M., Wheatley, D., Howell, A., Coombes, G., Sergenson, N., Sin, H.-J., Folkerd, E., Dowsett, M., …investigators, S. (2013). Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial. Lancet Oncology, 14(10), 989-998. https://doi.org/10.1016/S1470-2045%2813%2970322-X

Journal Article Type	Article
Online Publication Date	Jul 29, 2013
Publication Date	2013-09
Deposit Date	Aug 29, 2023
Journal	LANCET ONCOLOGY
Print ISSN	1470-2045
Electronic ISSN	1474-5488
Publisher	Elsevier
Peer Reviewed	Peer Reviewed
Volume	14
Issue	10
Pages	989-998
DOI	https://doi.org/10.1016/S1470-2045%2813%2970322-X
Public URL	https://keele-repository.worktribe.com/output/559775

Hypofractionation: The standard for external beam breast irradiation (2023)
Journal Article

Breast cancer radiation therapy - Authors' reply. (2020)
Journal Article

FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 5-year results (2020)
Journal Article

Can patients with multiple breast cancers in the same breast avoid mastectomy by having multiple lumpectomies to achieve equivalent rates of local breast cancer recurrence? A randomised controlled feasibility trial called MIAMI UK (2019)
Journal Article

Downloadable Citations

HTML

BIB

RTF

Authors

Citation

You might also like

Downloadable Citations